BioAffinity Technologies宣佈註冊直接發行和同時定向增發以及發行權證

快訊 · 08/02 21:25

BioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

BioAffinity Technologies宣佈註冊直接發行和同時定向增發以及發行權證，籌集總收益爲175萬美元。